A prospective observational study to assess effectiveness of the training and risk minimisation measures recommended for the usage of the diagnostic agent NeuraCeqTM in the post-authorisation clinical situation: A post-authorisation safety study (PASS)

21/01/2016
11/03/2021
EU PAS number:
EUPAS12145
Study
Finalised

ENCePP Code of conduct

No
Data sources

Data sources (types)

Other

Data sources (types), other

Visual assessment results of 20 PET scan cases previously assessed by two independent experts (to achieve the first goal, the primary objective 1 - effectiveness of training material).Answers of a multiple choice questionnaire (to achieve the second goal, the primary objective 2 - monitoring the effectiveness of risk minimisation measures.
Use of a Common Data Model (CDM)

CDM mapping

No
Data quality specifications

Check conformance

Unknown

Check completeness

Unknown

Check stability

Unknown

Check logical consistency

Unknown
Data characterisation

Data characterisation conducted

No